CYC - Daily General Banter & US Rollout, page-3

  1. 482 Posts.
    lightbulb Created with Sketch. 271
    What are your thoughts on the below announcement @Pozzo23?

    https://hotcopper.com.au/threads/ann-4dmedical-files-fda-submission-for-ctvq.8597580/

    4DMedical files FDA 510(k) submission for CT:VQ™, a non-contrast CT-based lung imaging software product for assessing both ventilation (V) and perfusion (Q) in the lungs.

    CT:VQ™ represents a revolution in ventilation perfusion imaging, solving key clinical and logistical limitations across all forms of nuclear ventilation perfusion imaging.

    CT:VQ™ solves key clinical and logistical limitations across all forms of nuclear VQ imaging:
    • No radiotracers – improved scheduling and accessibility
    • Simplified workflows – integrated into routine CT imaging without any additional infrastructure
    • Higher resolution and quantification without artifacts caused by clumping or leakage of contrast
    • Large install base – leverages the ~14,500 installed CT scanners across the U.S. healthcare system,
    including rural and smaller healthcare facilities, which may not have existing nuclear VQ
    infrastructure

    With the clinical and logistical advantages CT:VQ™ has over traditional nuclear VQ imaging modalities, 4DMedical believes it can rapidly capture a significant part of this market, and over time expects to displace 100% of all nuclear VQ scans.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.12
Change
0.155(16.2%)
Mkt cap ! $123.9M
Open High Low Value Volume
96.0¢ $1.17 96.0¢ $178.6K 169.4K

Buyers (Bids)

No. Vol. Price($)
1 950 $1.05
 

Sellers (Offers)

Price($) Vol. No.
$1.12 500 1
View Market Depth
Last trade - 16.10pm 04/07/2025 (20 minute delay) ?
CYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.